High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 4, 2011, Pages 261-264

  Vishwanathan, Sundaram A ^a   Guenthner, Patricia C ^a   Lin, Carol Y ^a   Dobard, Charles ^a   Sharma, Sunita ^a   Adams, Debra R ^a   Otten, Ron A ^a   Heneine, Walid ^a   Hendry, R Michael ^a   McNicholl, Janet M ^a   Kersh, Ellen N ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV 1; menstrual cycle; pigtail macaque; progesterone; SHIV; susceptibility

Indexed keywords

PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRACEPTION; EXPOSURE; FEMALE; FOLLICULAR PHASE; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION SENSITIVITY; LUTEAL PHASE; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA; VIREMIA; VIRUS IMMUNITY; VIRUS TRANSMISSION;

ANIMALS; DISEASE SUSCEPTIBILITY; FEMALE; HIV-1; LUTEAL PHASE; MACACA NEMESTRINA; PREGNANCY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA; VIRAL LOAD; VIREMIA;

EID: 79959938249     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318220ebd3     Document Type: Article

References (22)

1. Hladik F, Hope TJ. HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep. 2009;6:20-28.
2. Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005;366: 1182-1188. (Pubitemid 41393596)
3. Sheffield JS,Wendel GD Jr, McIntire DD, et al. The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod Sci. 2009; 16:20-31.
4. Baeten JM, Lavreys L, Sagar M, et al. Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. J Acquir Immune Defic Syndr. 2005;38:S18-S21.
5. Morrison CS, Chen PL, Kwok C, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS. 17;24: 1778-1781.
6. Wira CR, Fahey JV. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS. 2008;22:1909-1917.
7. Sodora DL, Gettie A, Miller CJ, et al. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses. 1998;14:S119-S123. (Pubitemid 28208902)
8. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med. 1996;2: 1084-1089. (Pubitemid 26338626)
9. Smith SM, Mefford M, Sodora D, et al. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS. 2004;18:1637-1643. (Pubitemid 39095780)
10. Harouse JM, Gettie A, Tan RC, et al. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science. 1999; 284:816-819. (Pubitemid 29291349)
11. Blakley GB, Beamer TW, Dukelow WR. Characteristics of the menstrual cycle in nonhuman primates. IV. Timed mating in Macaca nemestrina. Lab Anim. 1981;15:351-353. (Pubitemid 12209975)
12. Parikh UM, Dobard C, Sharma S, et al. Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine. J Virol. 2009;83:10358-10365.
13. Otten RA, Adams DR, Kim CN, et al. Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis. 2005;191: 164-173. (Pubitemid 40096373)
14. Saltzman W, Schultz-Darken NJ, Scheffler G, et al. Social and reproductive influences on plasma cortisol in female marmoset monkeys. Physiol Behav.;56:801-810.
15. Poonia B, Walter L, Dufour J, et al. Cyclic changes in the vaginal epithelium of normal rhesus macaques. J Endocrinol. 2006;190: 829-835. (Pubitemid 44560256)
16. Trunova N, Tsai L, Tung S, et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology. 2006;352:169-177. (Pubitemid 44142685)
17. Hel Z, Stringer E, Mestecky J. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev. 2010;31:79-97.
18. Liu J, Keele BF, Li H, et al. Low dose mucosal SIV infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J Virol. 2010;84:10406-10412.
19. Jiang Y, Tian B, Saifuddin M, et al. RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models. AIDS Res Ther. 2009;6:23.
20. Veazey RS, Shattock RJ, Pope M, et al. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med. 2003;9:343-346. (Pubitemid 36362791)
21. Lai SK, Hida K, Shukair S, et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol. 2009;83:11196-11200.
22. Ghosh M, Fahey JV, Shen Z, et al. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and-negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One. 5:e11366.